```html

Woolly Hair Loss (Trichorrhexis Nodosa‑like Alopecia)

What is Woolly hair loss?

Woolly hair loss describes a pattern of thinning or shedding that occurs in people with “woolly” hair—hair that is tightly curled, fine‑textured, and often appears dry or frizzy. The term is most frequently used in dermatology to refer to a specific type of alopecia that accompanies a hereditary or acquired condition causing the hair shaft to be fragile and break easily, giving the hair a “wool‑like” appearance. Unlike common forms of hair loss such as androgenetic alopecia, woolly hair loss typically begins in childhood or early adulthood and may be associated with other skin, eye, or systemic findings.

Because the underlying cause can range from benign genetic variants to systemic diseases, a thorough evaluation is essential. The information below outlines the most common causes, associated symptoms, when to seek care, how clinicians diagnose the problem, and the treatment options available.

Common Causes

Below are the most frequently encountered conditions that can produce woolly hair loss. Each can present alone or as part of a syndrome.

• Autosomal‑Dominant Woolly Hair (ADWH): A hereditary disorder in which the hair shaft is intrinsically fragile, leading to breakage and diffuse thinning.
• Autosomal‑Recessive Woolly Hair (ARWH): Often more severe than the dominant form and may be linked to other ectodermal anomalies (e.g., palmoplantar keratoderma).
• Woolly Hair/Hypotrichosis Syndrome (WHHS): Combines woolly hair with sparse scalp hair; can be associated with cardiac or dental abnormalities.
• Trichorrhexis Nodosa (TN) secondary to chemical or mechanical damage: Repetitive heat styling, harsh brushes, or chemical relaxers weaken the hair shaft, creating “node‑like” breaks that mimic woolly hair loss.
• Hypothyroidism: Low thyroid hormone reduces hair follicle activity; the hair that does grow can become coarse, dry, and prone to breakage.
• Ringworm of the scalp (Tinea​ capitis): Fungal infection can cause broken, short hairs that appear woolly, especially in children.
• Ichthyosis vulgaris and other ectodermal dysplasias: Abnormal skin barrier leads to dry, brittle hair shafts.
• Congenital atrial septal defect syndromes (e.g., Naxos disease, Carvajal syndrome): Mutations in desmosomal proteins affect both heart and hair, resulting in woolly hair and progressive cardiomyopathy.
• Systemic lupus erythematosus (SLE) or discoid lupus: Autoimmune inflammation can cause scarring alopecia with a woolly texture.
• Nutritional deficiencies (zinc, biotin, essential fatty acids): Poor nutrition impairs keratin formation, leading to fragile, wool‑like hair.

Associated Symptoms

Depending on the root cause, patients with woolly hair loss may notice additional signs:

• Dry, frizzy or “spun‑metal” texture of the remaining hair.
• Breakage at the shaft, creating short “spike” hairs.
• Scalp itching or tenderness.
• Red, scaly patches (especially with tinea capitis or lupus).
• Palmar/plantar keratoderma, nail dystrophy, or dental anomalies (seen in ectodermal dysplasia syndromes).
• Cardiac symptoms—palpitations, shortness of breath, or family history of sudden cardiac death (important in Naxos/Carvajal disease).
• Generalized signs of hypothyroidism: fatigue, weight gain, cold intolerance.
• Systemic lupus signs: joint pain, photosensitivity, oral ulcers.
• Hair‑related cosmetic concerns: increased visibility of scalp, difficulty styling.

When to See a Doctor

Prompt evaluation is recommended if any of the following occur:

• Rapid or patchy hair loss that spreads over weeks.
• Associated scalp redness, scaling, pustules, or oozing.
• Itching or pain that does not improve with over‑the‑counter shampoos.
• Signs of systemic illness (fatigue, weight change, heart palpitations, joint pain).
• Family history of sudden cardiac death or known heart disease.
• New onset of hair loss after starting a medication, hair‑care product, or chemical treatment.

Diagnosis

Diagnosing woolly hair loss involves a combination of clinical assessment and targeted investigations.

Clinical Examination

• Detailed scalp inspection under magnification to note hair shaft morphology (e.g., nodes, tapering).
• Assessment of skin, nails, teeth, and cardiac exam if a syndrome is suspected.
• Family pedigree to identify hereditary patterns.

Diagnostic Tests

1. Trichoscopy (dermoscopy of hair): Reveals broken hairs, “comma‑shaped” or “corkscrew” fibers typical of woolly hair.
2. Hair shaft microscopy: Light or electron microscopy can confirm trichorrhexis nodosa or other structural defects.
3. Fungal culture or Wood’s lamp examination: Rules out tinea capitis.
4. Blood work: TSH, free T4, complete metabolic panel, zinc & biotin levels, ANA panel (for lupus), and CBC.
5. Genetic testing: Targeted panels for desmosomal gene mutations (DSP, JUP) or keratin/ectodermal dysplasia genes when a hereditary syndrome is suspected.
6. Cardiac evaluation: ECG and echocardiogram if Naxos/Carvajal disease is on the differential.

Treatment Options

Treatment is individualized based on the underlying cause. Below are both medical and home‑care measures.

Medical Therapies

• Antifungal agents: Oral griseofulvin or terbinafine for tinea capitis (usually 4–6 weeks). Topical selenium sulfide can reduce spore load.
• Thyroid hormone replacement: Levothyroxine for hypothyroidism; dose titrated to normalize TSH.
• Immunosuppressants for lupus: Hydroxychloroquine, low‑dose prednisone, or systemic agents for severe discoid lesions.
• Nutrient supplementation: Oral zinc (20–30 mg/day) or biotin (5 mg/day) when deficiencies are documented.
• Topical corticosteroids: Low‑potency steroids (e.g., hydrocortisone 1%) for inflammatory scalp patches.
• Desmosomal disease management: No disease‑modifying drugs yet; focus on cardiac surveillance and symptom control.
• Hair growth stimulants: Minoxidil 2 % or 5 % topical solution can improve density in non‑scarring woolly hair loss, though response varies.

Home & Lifestyle Measures

• Use a gentle, sulfate‑free shampoo and a wide‑tooth comb; avoid brushing wet hair.
• Limit heat styling (blow‑dryers, straighteners) to <10 minutes and keep temperature <180 °F.
• Apply a weekly deep‑conditioning mask containing argan oil, shea butter, or hydrolyzed keratin.
• Protect hair from UV exposure with hats or UV‑filtering sprays.
• Maintain a balanced diet rich in protein, omega‑3 fatty acids, iron, zinc, and vitamins A, C, D, and E.
• Manage stress—mind‑body techniques, regular exercise, adequate sleep have modest benefits for hair‑cycle regulation.

Prevention Tips

While genetic forms cannot be prevented, many acquired triggers are modifiable:

• Choose hair care products free of harsh sulfates, parabens, and alcohol.
• Avoid tight hairstyles (braids, ponytails) that create traction.
• Rinse hair thoroughly to remove product residue that can weaken shafts.
• Limit chemical processing (relaxers, perms, bleaching) and space treatments at least 8‑12 weeks apart.
• Screen for thyroid disease every 5‑7 years, especially if you have a family history of autoimmune disorders.
• Seek early treatment for scalp infections or dermatitis to prevent chronic damage.
• If you have a known cardiac‑hair syndrome, adhere to regular cardiac follow‑up; early detection of arrhythmias can mitigate life‑threatening complications.

Emergency Warning Signs

Bottom Line

Woolly hair loss is a distinctive form of alopecia that often signals an underlying dermatologic, endocrine, nutritional, or systemic condition. Early recognition, a thorough work‑up, and targeted therapy can halt progression, improve hair health, and, importantly, detect potentially life‑threatening associated diseases such as cardiomyopathy. If you notice brittle, wool‑like hair and any of the warning signs described above, schedule an appointment with a dermatologist or primary‑care provider promptly.

---

References: Mayo Clinic. “Hair loss.”; CDC. “Tinea capitis.”; National Institutes of Health. “Hypothyroidism.”; World Health Organization. “Lupus erythematosus.”; Cleveland Clinic. “Minoxidil for hair loss.”; Journal of the American Academy of Dermatology. 2022;86(4):742‑752.

```